中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2013年
5期
197-198
,共2页
小儿%呼吸道感染%继发腹泻
小兒%呼吸道感染%繼髮腹瀉
소인%호흡도감염%계발복사
children%Respiratory tract infections%Secondary to diarrhea
目的探讨小儿呼吸道感染继发腹泻的相关诊断及疗效。方法 将70例小儿呼吸道感染继发腹泻的患者，随机分为两组，试验组35例在常规抗病毒及敏感抗生素对症治疗的同时选用口服微生态制剂贝达飞胶囊对照组35例给予常规抗病毒及敏感抗生素的对症治疗，观察治疗3天至7天内两组继发腹泻病例数，对疗效进行分析判断。结果 试验组继发腹泻9例，发病率为25.71%，对照组继发腹泻18例，发病率为51.42%，两组比较差异有高度显著性（P<0.05）。结论小儿呼吸道感染时预防性口服微生态制剂选用贝飞达可以降低患儿继发腹泻的发生率，疗效明显，安全可靠。
目的探討小兒呼吸道感染繼髮腹瀉的相關診斷及療效。方法 將70例小兒呼吸道感染繼髮腹瀉的患者，隨機分為兩組，試驗組35例在常規抗病毒及敏感抗生素對癥治療的同時選用口服微生態製劑貝達飛膠囊對照組35例給予常規抗病毒及敏感抗生素的對癥治療，觀察治療3天至7天內兩組繼髮腹瀉病例數，對療效進行分析判斷。結果 試驗組繼髮腹瀉9例，髮病率為25.71%，對照組繼髮腹瀉18例，髮病率為51.42%，兩組比較差異有高度顯著性（P<0.05）。結論小兒呼吸道感染時預防性口服微生態製劑選用貝飛達可以降低患兒繼髮腹瀉的髮生率，療效明顯，安全可靠。
목적탐토소인호흡도감염계발복사적상관진단급료효。방법 장70례소인호흡도감염계발복사적환자，수궤분위량조，시험조35례재상규항병독급민감항생소대증치료적동시선용구복미생태제제패체비효낭대조조35례급여상규항병독급민감항생소적대증치료，관찰치료3천지7천내량조계발복사병례수，대료효진행분석판단。결과 시험조계발복사9례，발병솔위25.71%，대조조계발복사18례，발병솔위51.42%，량조비교차이유고도현저성（P<0.05）。결론소인호흡도감염시예방성구복미생태제제선용패비체가이강저환인계발복사적발생솔，료효명현，안전가고。
Objective Explore the diagnosis and treatment of respiratory tract infections in children secondary to diarrhea. Method 70 cases of children with respiratory tract infection secondary to diarrhea patients were randomly divided into two groups, the test group, 35cases in the conventional anti-viral and antibiotic sensitive symptomatic treatment of oral anti-viral selection Bifico control group of 35 patients received conventional antiviralthe sensitive antibiotics symptomatic treatment, observation and treatment 3 days to 7 days, the two groups to the number of secondary cases of diarrhea, and analysis to determine the efficacy.Result The secondary test group nine cases of diarrhea, the incidence rate of 25.71%, secondary to the control group,18cases of diarrhea, the incidence rate was 51.42%, the difference was highly significant (P <0.05).Conclusion Respiratory tract infections in children the preventive oral probiotics selection Bifico can reduce the incidence of diarrhea in children, obvious effect, safe and reliable.
